Copyright Reports & Markets. All rights reserved.

Global Vascular Disrupting Agents Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Vascular Disrupting Agents
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Vascular Disrupting Agents Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Oral
    • 1.3.3 Vein
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Vascular Disrupting Agents Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Specialty Clinic
    • 1.4.4 Others
  • 1.5 Global Vascular Disrupting Agents Market Size & Forecast
    • 1.5.1 Global Vascular Disrupting Agents Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Vascular Disrupting Agents Sales Quantity (2018-2029)
    • 1.5.3 Global Vascular Disrupting Agents Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 AGC Biologics
    • 2.1.1 AGC Biologics Details
    • 2.1.2 AGC Biologics Major Business
    • 2.1.3 AGC Biologics Vascular Disrupting Agents Product and Services
    • 2.1.4 AGC Biologics Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AGC Biologics Recent Developments/Updates
  • 2.2 Avid Bioservices
    • 2.2.1 Avid Bioservices Details
    • 2.2.2 Avid Bioservices Major Business
    • 2.2.3 Avid Bioservices Vascular Disrupting Agents Product and Services
    • 2.2.4 Avid Bioservices Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Avid Bioservices Recent Developments/Updates
  • 2.3 Bionomics
    • 2.3.1 Bionomics Details
    • 2.3.2 Bionomics Major Business
    • 2.3.3 Bionomics Vascular Disrupting Agents Product and Services
    • 2.3.4 Bionomics Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Bionomics Recent Developments/Updates
  • 2.4 Beijing Shenogen Biomedical
    • 2.4.1 Beijing Shenogen Biomedical Details
    • 2.4.2 Beijing Shenogen Biomedical Major Business
    • 2.4.3 Beijing Shenogen Biomedical Vascular Disrupting Agents Product and Services
    • 2.4.4 Beijing Shenogen Biomedical Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Beijing Shenogen Biomedical Recent Developments/Updates
  • 2.5 Mateon Therapeutics
    • 2.5.1 Mateon Therapeutics Details
    • 2.5.2 Mateon Therapeutics Major Business
    • 2.5.3 Mateon Therapeutics Vascular Disrupting Agents Product and Services
    • 2.5.4 Mateon Therapeutics Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Mateon Therapeutics Recent Developments/Updates
  • 2.6 Myrexis
    • 2.6.1 Myrexis Details
    • 2.6.2 Myrexis Major Business
    • 2.6.3 Myrexis Vascular Disrupting Agents Product and Services
    • 2.6.4 Myrexis Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Myrexis Recent Developments/Updates
  • 2.7 VBL Therapeutics
    • 2.7.1 VBL Therapeutics Details
    • 2.7.2 VBL Therapeutics Major Business
    • 2.7.3 VBL Therapeutics Vascular Disrupting Agents Product and Services
    • 2.7.4 VBL Therapeutics Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 VBL Therapeutics Recent Developments/Updates
  • 2.8 Steba biotech
    • 2.8.1 Steba biotech Details
    • 2.8.2 Steba biotech Major Business
    • 2.8.3 Steba biotech Vascular Disrupting Agents Product and Services
    • 2.8.4 Steba biotech Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Steba biotech Recent Developments/Updates
  • 2.9 BeyondSpring Pharmaceutical
    • 2.9.1 BeyondSpring Pharmaceutical Details
    • 2.9.2 BeyondSpring Pharmaceutical Major Business
    • 2.9.3 BeyondSpring Pharmaceutical Vascular Disrupting Agents Product and Services
    • 2.9.4 BeyondSpring Pharmaceutical Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BeyondSpring Pharmaceutical Recent Developments/Updates
  • 2.10 Immune Pharmaceuticals
    • 2.10.1 Immune Pharmaceuticals Details
    • 2.10.2 Immune Pharmaceuticals Major Business
    • 2.10.3 Immune Pharmaceuticals Vascular Disrupting Agents Product and Services
    • 2.10.4 Immune Pharmaceuticals Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Immune Pharmaceuticals Recent Developments/Updates
  • 2.11 Nereus Pharmaceuticals
    • 2.11.1 Nereus Pharmaceuticals Details
    • 2.11.2 Nereus Pharmaceuticals Major Business
    • 2.11.3 Nereus Pharmaceuticals Vascular Disrupting Agents Product and Services
    • 2.11.4 Nereus Pharmaceuticals Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Nereus Pharmaceuticals Recent Developments/Updates
  • 2.12 Madrigal Pharmaceuticals
    • 2.12.1 Madrigal Pharmaceuticals Details
    • 2.12.2 Madrigal Pharmaceuticals Major Business
    • 2.12.3 Madrigal Pharmaceuticals Vascular Disrupting Agents Product and Services
    • 2.12.4 Madrigal Pharmaceuticals Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Madrigal Pharmaceuticals Recent Developments/Updates
  • 2.13 Celgene Corporation
    • 2.13.1 Celgene Corporation Details
    • 2.13.2 Celgene Corporation Major Business
    • 2.13.3 Celgene Corporation Vascular Disrupting Agents Product and Services
    • 2.13.4 Celgene Corporation Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Celgene Corporation Recent Developments/Updates
  • 2.14 Bionomics
    • 2.14.1 Bionomics Details
    • 2.14.2 Bionomics Major Business
    • 2.14.3 Bionomics Vascular Disrupting Agents Product and Services
    • 2.14.4 Bionomics Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Bionomics Recent Developments/Updates
  • 2.15 Lees Pharmaceutical Holdings
    • 2.15.1 Lees Pharmaceutical Holdings Details
    • 2.15.2 Lees Pharmaceutical Holdings Major Business
    • 2.15.3 Lees Pharmaceutical Holdings Vascular Disrupting Agents Product and Services
    • 2.15.4 Lees Pharmaceutical Holdings Vascular Disrupting Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Lees Pharmaceutical Holdings Recent Developments/Updates

3 Competitive Environment: Vascular Disrupting Agents by Manufacturer

  • 3.1 Global Vascular Disrupting Agents Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Vascular Disrupting Agents Revenue by Manufacturer (2018-2023)
  • 3.3 Global Vascular Disrupting Agents Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Vascular Disrupting Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Vascular Disrupting Agents Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Vascular Disrupting Agents Manufacturer Market Share in 2022
  • 3.5 Vascular Disrupting Agents Market: Overall Company Footprint Analysis
    • 3.5.1 Vascular Disrupting Agents Market: Region Footprint
    • 3.5.2 Vascular Disrupting Agents Market: Company Product Type Footprint
    • 3.5.3 Vascular Disrupting Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Vascular Disrupting Agents Market Size by Region
    • 4.1.1 Global Vascular Disrupting Agents Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Vascular Disrupting Agents Consumption Value by Region (2018-2029)
    • 4.1.3 Global Vascular Disrupting Agents Average Price by Region (2018-2029)
  • 4.2 North America Vascular Disrupting Agents Consumption Value (2018-2029)
  • 4.3 Europe Vascular Disrupting Agents Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Vascular Disrupting Agents Consumption Value (2018-2029)
  • 4.5 South America Vascular Disrupting Agents Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Vascular Disrupting Agents Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Vascular Disrupting Agents Sales Quantity by Type (2018-2029)
  • 5.2 Global Vascular Disrupting Agents Consumption Value by Type (2018-2029)
  • 5.3 Global Vascular Disrupting Agents Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Vascular Disrupting Agents Sales Quantity by Application (2018-2029)
  • 6.2 Global Vascular Disrupting Agents Consumption Value by Application (2018-2029)
  • 6.3 Global Vascular Disrupting Agents Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Vascular Disrupting Agents Sales Quantity by Type (2018-2029)
  • 7.2 North America Vascular Disrupting Agents Sales Quantity by Application (2018-2029)
  • 7.3 North America Vascular Disrupting Agents Market Size by Country
    • 7.3.1 North America Vascular Disrupting Agents Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Vascular Disrupting Agents Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Vascular Disrupting Agents Sales Quantity by Type (2018-2029)
  • 8.2 Europe Vascular Disrupting Agents Sales Quantity by Application (2018-2029)
  • 8.3 Europe Vascular Disrupting Agents Market Size by Country
    • 8.3.1 Europe Vascular Disrupting Agents Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Vascular Disrupting Agents Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Vascular Disrupting Agents Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Vascular Disrupting Agents Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Vascular Disrupting Agents Market Size by Region
    • 9.3.1 Asia-Pacific Vascular Disrupting Agents Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Vascular Disrupting Agents Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Vascular Disrupting Agents Sales Quantity by Type (2018-2029)
  • 10.2 South America Vascular Disrupting Agents Sales Quantity by Application (2018-2029)
  • 10.3 South America Vascular Disrupting Agents Market Size by Country
    • 10.3.1 South America Vascular Disrupting Agents Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Vascular Disrupting Agents Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Vascular Disrupting Agents Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Vascular Disrupting Agents Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Vascular Disrupting Agents Market Size by Country
    • 11.3.1 Middle East & Africa Vascular Disrupting Agents Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Vascular Disrupting Agents Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Vascular Disrupting Agents Market Drivers
  • 12.2 Vascular Disrupting Agents Market Restraints
  • 12.3 Vascular Disrupting Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Vascular Disrupting Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Vascular Disrupting Agents
  • 13.3 Vascular Disrupting Agents Production Process
  • 13.4 Vascular Disrupting Agents Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Vascular Disrupting Agents Typical Distributors
  • 14.3 Vascular Disrupting Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Vascular Disrupting Agents market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Vascular Disrupting Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Vascular Disrupting Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Vascular Disrupting Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Vascular Disrupting Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Vascular Disrupting Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Vascular Disrupting Agents
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Vascular Disrupting Agents market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AGC Biologics, Avid Bioservices, Bionomics, Beijing Shenogen Biomedical and Mateon Therapeutics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Vascular Disrupting Agents market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral
    Vein
    Market segment by Application
    Hospital
    Specialty Clinic
    Others
    Major players covered
    AGC Biologics
    Avid Bioservices
    Bionomics
    Beijing Shenogen Biomedical
    Mateon Therapeutics
    Myrexis
    VBL Therapeutics
    Steba biotech
    BeyondSpring Pharmaceutical
    Immune Pharmaceuticals
    Nereus Pharmaceuticals
    Madrigal Pharmaceuticals
    Celgene Corporation
    Bionomics
    Lees Pharmaceutical Holdings
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Vascular Disrupting Agents product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Vascular Disrupting Agents, with price, sales, revenue and global market share of Vascular Disrupting Agents from 2018 to 2023.
    Chapter 3, the Vascular Disrupting Agents competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Vascular Disrupting Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vascular Disrupting Agents market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Vascular Disrupting Agents.
    Chapter 14 and 15, to describe Vascular Disrupting Agents sales channel, distributors, customers, research findings and conclusion.

    Buy now